Korean Government Task Force Uncovers Illegal Rebates From Device Firms
This article was originally published in PharmAsia News
With the help of state prosecutors, Korea’s health ministry expands the scope of anti-rebate surveillance to the medical device sector.
You may also be interested in...
Multiple IPF drugs are being rushed into Phase III based on early-stage signals of efficacy and safety presented at the ATS meeting. Scrip spoke with the University of Pittsburgh's Kevin Gibson about the candidates, trial design, combination therapy and limitations of current therapy.